Functionality in patients with newly diagnosed schizophrenia treated with paliperidone palmitate 3-month formulation in real-world clinical practice study (TIME study)

dc.contributor.author	García-Portilla González, María Paz
dc.contributor.author	Gómez, F.
dc.contributor.author	Benito, A.
dc.contributor.author	López, P.
dc.contributor.author	García, M.
dc.date.accessioned	2021-06-29T08:57:46Z
dc.date.available	2021-06-29T08:57:46Z
dc.date.issued	2020
dc.identifier.issn	0924-977X
dc.identifier.issn	1873-7862
dc.identifier.uri	http://hdl.handle.net/10651/59165
dc.description	Congress of the European College of Neuropsychopharmacology (ECNP) (33rd. 2020. Vienna)
dc.language.iso	eng
dc.relation.ispartof	European Neuropsychopharmacology
dc.rights	© 2020 Published by Elsevier B.V.
dc.source	WOS:000593520800597
dc.title	Functionality in patients with newly diagnosed schizophrenia treated with paliperidone palmitate 3-month formulation in real-world clinical practice study (TIME study)
dc.type	conference output	spa
dc.identifier.doi	10.1016/j.euroneuro.2020.09.611
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.euroneuro.2020.09.611

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.